lidor vet. 20 mg/ml injektioneste, liuos
vetviva richter gmbh - lidocaine hydrochloride monohydrate - injektioneste, liuos - 20 mg/ml - lidokaiini
calcibel forte 380/60/50 mg/ml infuusioneste, liuos
bela-pharm gmbh & co. kg - boric acid, calcium gluconate, magnesium chloride hexahydrate - infuusioneste, liuos - 380/60/50 mg/ml - kalsiumin yhdistelmävalmisteet d-vitamiinin ja/tai muiden lääkeaineiden kanssa
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfooma, mantle-cell - antineoplastiset aineet - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
norflex 100 mg depottabletti
viatris oy - orphenadrine citrate - depottabletti - 100 mg - orfenadriini
norflex 30 mg/ml injektioneste, liuos
viatris oy - orphenadrine citrate - injektioneste, liuos - 30 mg/ml - orfenadriini
lastin 0,13 mg/annos nenäsumute, liuos
viatris oy - azelastine hydrochloride - nenäsumute, liuos - 0,13 mg/annos - atselastiini
naloxon b. braun 0.4 mg/ml injektio-/infuusioneste, liuos
b. braun melsungen ag - naloxone hydrochloride dihydrate - injektio-/infuusioneste, liuos - 0.4 mg/ml - naloksoni